diabetes

Showing NaN - NaN of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolic Parameters 3 Months, 9 Months, and 2 Years After

Completed
  • Obesity
  • +3 more
  • Bariatric surgery
  • Houston, Texas
    University of Texas, Health Sciences Center Houston
Nov 3, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Oct 26, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Glendale, Arizona
  • +87 more
Aug 10, 2020

Diabetes, Diabetes Type 2 Trial in United States (Liraglutide, Metformin, Placebo)

Completed
  • Diabetes
  • Diabetes Mellitus Type 2
  • Chino, California
  • +19 more
Jul 20, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

Completed
  • Stroke
  • +2 more
  • Birmingham, Alabama
  • +182 more
Apr 14, 2020

Diabetes Trial in United States (GuardianĀ® blood-sugar monitoring device)

Terminated
  • Diabetes
  • GuardianĀ® blood-sugar monitoring device
  • Dallas, Texas
  • +5 more
Mar 6, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Accidental Falls, Fall Due to Loss of Equilibrium, High Risk of Falls Due to Mobility Limitation Trial in Houston (MBB AFO,

Completed
  • Accidental Falls
  • +8 more
  • MBB AFO
  • Control
  • Houston, Texas
    Baylor College of Medicine
Feb 26, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +118 more
Jan 8, 2020

Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of

Completed
  • Acute Ischemic Stroke
  • +2 more
  • IV insulin to maintain target glucose concentration of 80-130 mg/dL
  • Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
  • Tucson, Arizona
  • +69 more
Dec 13, 2019

Diabetes, Type 1 Diabetes Trial in Chicago, Boston, Houston (Blood testing)

Completed
  • Diabetes
  • Type 1 Diabetes
  • Blood testing
  • Chicago, Illinois
  • +2 more
Dec 14, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Muscle Shoals, Alabama
  • +142 more
Nov 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +208 more
Oct 2, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • +2 more
  • Mobile, Alabama
  • +190 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • basal insulin
  • Birmingham, Alabama
  • +57 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019